$2.17
-0.03 (-1.36%)
Open$2.35
Previous Close$2.20
Day High$2.38
Day Low$2.16
52W High$25.00
52W Low$1.70
Volume—
Avg Volume39.8K
Market Cap164.33M
P/E Ratio—
EPS$-1.14
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 674.0K | 122.20M | 119.09M |
| Net Income | -9,435,647 | 29.08M | 25.78M |
| Profit Margin | -1,392.6% | 23.8% | 21.7% |
| EBITDA | -5,967,327 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |